Evidence map›Paper›PMID 40336121›Full record

ArticleMalaria journal2025

Integrating local malaria molecular monitoring into regular malaria indicator surveys on Bioko Island: high association between urban communities and low-density infections.

Thomas C Stabler, Salome Hosch, Elizabeth Nyakarungu, Johanna Nouria Giger, Monserrat Kobe Elonga, Rosalia Nzang Bibang, Victoria Mangue Ndong, Ilda Elobe Mometolo, Alejandro Lopelo Bolopa, Rosa Maria Oko Bedoung and 15 more

Abstract read
In one paragraph

Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Thomas C StablerDepartment of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland. thomas.stabler@swisstph.ch.
Salome HoschDepartment of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
Elizabeth NyakarunguMCD Global Health, Malabo, Equatorial Guinea.
Johanna Nouria GigerDepartment of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.
Monserrat Kobe ElongaBaney Reference Laboratory, Baney, Equatorial Guinea.
Rosalia Nzang BibangBaney Reference Laboratory, Baney, Equatorial Guinea.
Victoria Mangue NdongBaney Reference Laboratory, Baney, Equatorial Guinea.
Ilda Elobe MometoloBaney Reference Laboratory, Baney, Equatorial Guinea.
Alejandro Lopelo BolopaBaney Reference Laboratory, Baney, Equatorial Guinea.
Rosa Maria Oko BedoungBaney Reference Laboratory, Baney, Equatorial Guinea.
Jose Raso BijeriBaney Reference Laboratory, Baney, Equatorial Guinea.
Esperanza Willy RokaBaney Reference Laboratory, Baney, Equatorial Guinea.
Ana Gertrudis NguemaBaney Reference Laboratory, Baney, Equatorial Guinea.
Victoria Palacios IchindaBaney Reference Laboratory, Baney, Equatorial Guinea.
Salvador BakaleBaney Reference Laboratory, Baney, Equatorial Guinea.
Cristina Nka EsokoleteBaney Reference Laboratory, Baney, Equatorial Guinea.
Matilde Riloha RivasEquatorial Guinea Ministry of Health and Social Welfare, Malabo, Equatorial Guinea.
David S GalickMCD Global Health, Malabo, Equatorial Guinea.
Wonder Philip PhiriMCD Global Health, Malabo, Equatorial Guinea.
Carlos A GuerraMCD Global Health, Silver Spring, Maryland, USA.
Guillermo A GarcíaMCD Global Health, Silver Spring, Maryland, USA.
Luca MontemartiniDiaxxo AG, Zurich, Switzerland.
Tobias SchindlerDiaxxo AG, Zurich, Switzerland.
Joana C SilvaDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA.
Claudia DaubenbergerDepartment of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland. claudia.daubenberger@swisstph.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEffective malaria control requires accurate identification of Plasmodium infections to tailor interventions appropriately. Rapid diagnostic tests (RDTs) are crucial tools for this purpose due to their small size and ease-of-use functionality. These tests typically target the Plasmodium falciparum histidine-rich protein 2 (HRP2) antigen. However, some strains of P. falciparum have deletions in the hrp2 and hrp3 genes, which may result in a false negative diagnosis using HRP2-based RDTs. Additionally, RDTs have a detection limit of 100 parasites per microlitre, insufficient for identifying low-density infections that sustain malaria transmission. This study explores integrating molecular monitoring using a novel cartridge-based PCR test, PlasmoPod, using samples from a malaria indicator survey (MIS) on Bioko Island, Equatorial Guinea to enhance detection of low-density infections and inform targeted malaria control strategies.

methodsThe study utilized a combination of RDTs and the DiaxxoPCR device for molecular monitoring. The device DiaxxoPCR uses a prefilled cartridge system, termed PlasmoPod for a malaria-based assay that employs a qPCR assay targeting 18S rDNA/rRNA. Samples from the 2023 MIS were extracted from dried blood spots (DBS), qPCR run in duplicate on the PlasmoPod. Epidemiological data from the MIS were merged with molecular data and the association between MIS variables to malaria infection by qPCR, and low-density infections were measured.

resultsThe integration of molecular monitoring revealed a proportion of low-density infections that circumvented RDTs diagnosis. Notably, individuals in urban communities and those reporting recent fever were more likely to harbour low-density, asymptomatic malaria infections. Findings suggest that urban residents, although less associated to malaria infection than rural residents by both RDT and qPCR, may be serving as a transmission reservoir. The relationship between low-density infections and individuals who recently reported fever may reflect recent anti-malarial treatment or natural clearance, and thus have lingering parasites in their blood.

conclusionThe study highlights the limitations of HRP2-based RDTs in detecting low density infections and underscores the potential of molecular tools like PlasmoPod in malaria surveillance. By identifying elusive transmission reservoirs and tracking parasite importation, molecular monitoring can play a crucial role in achieving malaria elimination. The findings advocate for the broader implementation of molecular diagnostics in malaria programs, especially in areas with low transmission, to enhance the detection and targeting of hidden reservoirs of infection.

Indexed as

Diagnostic Tests, RoutineEpidemiological MonitoringMalaria, FalciparumMolecular Diagnostic TechniquesPlasmodium falciparumAdolescentAdultAgedAntigens, ProtozoanChildChild, PreschoolEquatorial GuineaFemaleHumansInfantMaleAntigens, ProtozoanProtozoan ProteinsRNA, Ribosomal, 18SBioko IslandLow density infectionsMalariaPlasmodium falciparumPlasmoPod

Identifiers

PMID40336121
PMCPMC12057208

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.